Muriel Audit

Study Director

GenoSafe

Muriel Audit

Holder of a PhD in Biology from the Montpellier II University, Muriel takes the position of Analytical Methods Development Manager at Genethon in 1999. She mainly focuses her work on control methods of gene therapy trials with viral vectors, specifically biosafety tests used in the frame of the first European gene therapy trial with an HIV derived vector.

Since 2003 she takes part as an expert in “gene and cell therapy” groups of French and European Pharmacopeia.
Muriel Audit is Study Director of GenoSafe since May 2007.